VšĮ Respublikinė Panevėžio ligoninė – regioninė gydymo įstaiga, teikianti diagnostikos, gydymo, reabilitacijos bei slaugos paslaugas. Ligoninė įsikūrusi Smėlynės g. 25, Panevėžyje. Ligoninė atlieka Panevėžio ir apskrities ligoninės funkcijas.

During the past decade, Respublikine Panevezio ligonine conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Respublikine Panevezio ligonine" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored and "Regeneron Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Respublikine Panevezio ligonine" #1 collaborator was "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Respublikine Panevezio ligonine" are "Ulcerative Colitis" (2 trials), "Acute Myocardial Infarction" (1 trials), "Non-Small Cell Lung Cancer" (1 trials), "Osteoarthritis, Hip" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "Respublikine Panevezio ligonine" in a lesser frequency.

Most popular intervention types in "Respublikine Panevezio ligonine" are "Drug" (5 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apremilast 20mg" (1 trials), "Apremilast 30mg" (1 trials), "Atezolizumab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Respublikine Panevezio ligonine" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Respublikine Panevezio ligonine". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Respublikine Panevezio ligonine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Respublikine Panevezio ligonine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Respublikine Panevezio ligonine has several departments that took part in Clinical trials: "Republican Panevezys Hospital, Department of Gastroenterology" - 3 trials